LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
XPEL
XPEL, Inc.
XPEL has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XPEL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
XPEL's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
XPEL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $37.62 | — |
| Current | 18x | $37.62 | — |
| Cheap | 22x | $46.19 | +23% |
| Fair | 33x | $68.12 | +81% |
| Expensive | 58x | $121 | +222% |
Historical ranges are pointers, not guarantees.
XPEL's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XPEL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for XPEL, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
XPEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.33 | +11% |
| Q3 2026 | $2.09 | +23% |
| Q2 2026 | $1.97 | +11% |
| Q1 2026 | $1.91 | +11% |
| Q4 2025 | $1.85 | +12% |
| Q3 2025 | $1.70 | -3.4% |
| Q2 2025 | $1.77 | +3.5% |
| Q1 2025 | $1.72 | -1.1% |
| Q4 2024 | $1.65 | -14% |
XPEL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over XPEL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
XPEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $137.8M | +9.9% |
| Q2 2026 | $143.1M | +15% |
| Q1 2026 | $117.4M | +13% |
| Q4 2025 | $122.3M | +14% |
| Q3 2025 | $125.4M | +11% |
| Q2 2025 | $124.7M | +13% |
| Q1 2025 | $103.8M | +15% |
| Q4 2024 | $107.5M | +1.9% |
XPEL's revenue has grown year over year every quarter since late 2020: $138M last quarter, up 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +1.9 points |
| Q2 2026 | 16% | +0.8 points |
| Q1 2026 | 11% | +0.4 points |
| Q4 2025 | 13% | +1.2 points |
| Q3 2025 | 13% | -2.9 points |
| Q2 2025 | 15% | -2 points |
| Q1 2025 | 11% | +0.5 points |
| Q4 2024 | 11% | -2 points |
XPEL has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
XPEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $19.2M | -40% |
| Q2 2026 | -$34.3M | -227% |
| Q1 2026 | -$2.3M | -205% |
| Q4 2025 | $1.6M | -66% |
| Q3 2025 | $32.2M | +76% |
| Q2 2025 | $26.9M | +7.4% |
| Q1 2025 | $2.2M | +$9.2M |
| Q4 2024 | $4.7M | +$7.4M |
XPEL has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XPEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
XPEL has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
XPEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 13.9 | Oversold |
XPEL's weekly RSI is 37 (neutral) and its Stochastic is 14 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
XPEL PE vs Consumer Cyclical Sector
| Metric | XPEL | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.1% below |
| PE % | 1 | 47 | 46 pts below |
XPEL is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
XPEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.7 | 12% below |
| 20 week MA | $45.5 | 17% below |
| 50 week MA | $46.5 | 19% below |
| 100 week MA | $41.2 | 8.7% below |
| 200 week MA | $49.2 | 24% below |
XPEL is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
XPEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.6 | $51.5 | +252% |
| 2021 | $51.5 | $68.5 | +33% |
| 2022 | $68.5 | $59.1 | -14% |
| 2023 | $59.1 | $53.9 | -8.9% |
| 2024 | $53.9 | $39.7 | -26% |
| 2025 | $39.7 | $52.1 | +31% |
| 2026 YTD | $52.1 | $37.6 | -28% |
XPEL has the edge over LCID on returns for 2026, with the stronger performance.